Pricing Log in Create free account

Matinas Biopharma Holdings, Inc. (MTNB) vs Notable Labs, Ltd. (NTBLQ)

Matinas Biopharma Holdings, Inc. and Notable Labs, Ltd. are both Biotechnology companies. Matinas Biopharma Holdings, Inc. and Notable Labs, Ltd. are of similar size ($2.4M and $2.4M). Matinas Biopharma Holdings, Inc. grew revenue faster over the last twelve months: 2,139.4% against −129.0%. Notable Labs, Ltd. has the higher net margin (6,350.6% vs 0.00%) and the higher return on invested capital (−295.4% vs −419.3%). Across the 16 metrics below, Notable Labs, Ltd. leads on 11 and Matinas Biopharma Holdings, Inc. on 5.

Valuation

Metric MTNB NTBLQ Biotechnology median
P/E n/m n/m 8.50
P/S 0.24 n/m 9.71
P/B 0.56 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.25 0.64
EV/Sales 0.05 23.30 9.21
Earnings yield (348.48%) 0.00% (33.15%)
Free cash flow yield (602.45%) 0.00% (25.50%)

Profitability

Metric MTNB NTBLQ Biotechnology median
Gross margin 0.00% 116.87% 65.16%
Operating margin 0.00% 9,259.04% 0.00%
Net margin 0.00% 6,350.60% 0.00%
Free cash flow margin 0.00% 9,158.43% 0.00%
Return on equity (154.28%) (79.79%) (56.36%)
Return on assets (98.53%) (59.14%) (48.04%)
Return on invested capital (419.27%) (295.36%) 0.00%

Growth

Metric MTNB NTBLQ Biotechnology median
Revenue growth (TTM) 2,139.41% (129.02%) 6.02%
EPS growth (last fiscal year) 62.08% 84.47% 30.26%
Revenue growth, 5-year CAGR 55.69% (11.93%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MTNB NTBLQ Biotechnology median
Debt to equity 0.00 0.03 0.00
Current ratio 0.85 2.77 4.72
Net debt to EBITDA 0.62 0.80 0.96

Dividend

Metric MTNB NTBLQ Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MTNB NTBLQ Biotechnology median
Market cap 2.37m 2.39m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack